---
kind: "section"
citation: "21 U.S.C. § 399j"
title: "21"
title_heading: "Food and Drugs"
number: "399j"
heading: "Abraham Accords Office"
release: "119-102"
url: "https://uscodex.org/usc/21/399j"
units:
  - "Chapter 9 — Federal Food, Drug, and Cosmetic Act"
  - "Subchapter X — Miscellaneous"
---

# §399j. Abraham Accords Office

- (a) **In general—** The [Secretary](/usc/21/321.md?p=d), acting through the [Commissioner](/usc/21/321.md?p=ee) of [Food](/usc/21/321.md?p=f) and [Drugs](/usc/21/321.md?p=g-1), shall establish within the [Food](/usc/21/321.md?p=f) and [Drug](/usc/21/321.md?p=g-1) Administration an [office](/usc/21/1701.md?p=14), to be known as the Abraham Accords [Office](/usc/21/1701.md?p=14), to be headed by a director.
- (b) **Office—** Not later than 2 years after February 3, 2026, the [Secretary](/usc/21/321.md?p=d) shall—
  - (1) in consultation with the governments of [Abraham Accords countries](#d), as well as appropriate United States Government diplomatic and security personnel—
    - (A) select the location of the Abraham Accords [Office](/usc/21/1701.md?p=14) in an [Abraham Accords country](#d); and
    - (B) establish such [office](/usc/21/1701.md?p=14); and
  - (2) assign to such [office](/usc/21/1701.md?p=14) such personnel of the [Food](/usc/21/321.md?p=f) and [Drug](/usc/21/321.md?p=g-1) Administration as the [Secretary](/usc/21/321.md?p=d) determines necessary to carry out the functions of such [office](/usc/21/1701.md?p=14).
- (c) **Duties—** The [Secretary](/usc/21/321.md?p=d), acting through the Director of the Abraham Accords [Office](/usc/21/1701.md?p=14), shall—
  - (1) after the Abraham Accords [Office](/usc/21/1701.md?p=14) is established—
    - (A) as part of the [Food](/usc/21/321.md?p=f) and [Drug](/usc/21/321.md?p=g-1) Administration’s work to strengthen the international oversight of regulated commodities, provide technical assistance to regulatory partners in [Abraham Accords countries](#d) on strengthening regulatory oversight and converging regulatory requirements for the oversight of regulated [products](/usc/21/360eee.md?p=13), including good manufacturing practices and other issues relevant to manufacturing medical [products](/usc/21/360eee.md?p=13) that are regulated by the [Food](/usc/21/321.md?p=f) and [Drug](/usc/21/321.md?p=g-1) Administration; and
    - (B) facilitate interactions between the [Food](/usc/21/321.md?p=f) and [Drug](/usc/21/321.md?p=g-1) Administration and interested parties in [Abraham Accords countries](#d), including by sharing relevant information regarding United States regulatory pathways with such parties, and facilitate feedback on the research, development, and manufacturing of [products](/usc/21/360eee.md?p=13) regulated in accordance with this chapter; and
  - (2) carry out other functions and activities as the [Secretary](/usc/21/321.md?p=d) determines to be necessary to carry out this section.
- (d) **Abraham Accords country defined—** In this section, the term “Abraham Accords country” means a country identified by the Department of State as having signed the Abraham Accords Declaration.
- (e) **National security—** Nothing in this section shall be construed to require any action inconsistent with a national security recommendation provided by the Federal Government.

## Source credit

(June 25, 1938, ch. 675, § 1015, as added Pub. L. 119–75, div. J, title VI, § 6611(a), Feb. 3, 2026, 140 Stat. 701.)

## Notes

### Editorial Notes